home / stock / bfri / bfri news

BFRI News and Press, Biofrontera Inc. From 01/13/22

Stock Information
Company Name: Biofrontera Inc.
Stock Symbol: BFRI
Market: NASDAQ
Website: biofrontera-us.com
Menu
BFRI BFRI Quote BFRI Short BFRI News BFRI Articles BFRI Message Board
Get BFRI Alerts

News, Short Squeeze, Breakout and More Instantly...
BFRI - Biofrontera Inc. Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021

WOBURN, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced preliminary, unaudited revenue for the quarter and full y...
BFRI - Biofrontera Inc. Announces Participation in Two Dermatology Conferences in January

WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that it plans to participate in the following two dermato...

BFRI - Is Biofrontera a Winner in the Biopharmaceutical Industry?

Biopharmaceutical company Biofrontera (BFRI) made its stock market debut on October 29, 2021, and hit its 52-week high of $14.63 on December 21, 2021. However, is it wise to buy the stock now despite the company being in its early stages of development? Let’s find out. Dermatologi...

BFRI - Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises

WOBURN, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) , a biopharmaceutical company specializing in the commercialization of dermatological products, announced that through the exercise of outstanding warrants the majority ownership of Biofrontera AG w...
BFRI - FTFT, NXTD and PIXY among mid-day movers

Gainers: Altamira Therapeutics (NASDAQ:CYTO) +37%. Takung Art (NYSE:TKAT) +34%. ShiftPixy (NASDAQ:PIXY) +37%. Pop Culture (NASDAQ:CPOP) +36%. Insignia Systems (NASDAQ:ISIG) +19%. Siyata (NASDAQ:SYTA) +16%. Calix (NYSE:CALX) +15%. WISeKey (NASDAQ:WKEY) +12%. Biofrontera (NASDAQ:BFRI) +13%. Law...

BFRI - MedAvail, Altamira Therapeutics leads healthcare gainers; Chembio Diagnostics, Gamida Cell among major losers

Gainers: MedAvail (NASDAQ:MDVL) +17%, Altamira Therapeutics (NASDAQ:CYTO) +17%, Orchard Therapeutics (NASDAQ:ORTX) +10%,Biofrontera (NASDAQ:BFRI) +9%, XORTX Therapeutics (NASDAQ:XRTX) +7%. Losers: Chembio Diagnostics (NASDAQ:CEMI) -16%, Gamida Cell (NAS...

BFRI - ISIG, CPOP and BFRI among mid-day movers

Gainers: Insignia Systems (NASDAQ:ISIG) +83%.. Pop Culture (NASDAQ:CPOP) +24%. Regencell Bioscience RGC +20% BridgeBio Pharma BBIO +19%. Gamida Cell (NASDAQ:GMDA) +17%. ADDvantage Technologies (NASDAQ:AEY) +17%. Centogene (NASDAQ:CNTG) +14% Altamira Therapeu...
BFRI - Altamira Therapeutics, Regencell Bioscience leads healthcare gainers; Biofrontera, Microbot Medical among major losers

Gainers: Altamira Therapeutics (NASDAQ:CYTO) +21%, Regencell Bioscience (NASDAQ:RGC) +17%, BridgeBio Pharma BBIO +13%, ImmunityBio (NASDAQ:IBRX) +8%, BiondVax Pharmaceuticals BVXV +8%. Losers: Biofrontera (NASDAQ:BFRI) -21%, Microbot Medical (...

BFRI - 3 Best Performing Healthcare IPOs in 2021

The healthcare sector has gained significant importance since the onset of the pandemic. Moreover, the industry is evolving with unique product launches and technological advancements. The healthcare sector has seen several IPOs this year. Healthcare companies 2seventy (TSVT), Regencell (RGC)...

BFRI - Is Biofrontera Stock A Buy Or Sell? Several Catalysts In 2022

Biofrontera is eyeing significant growth opportunities for its FDA-approved skin disease photodynamic therapy drug "Ameluz". Updates regarding several ongoing clinical studies for expanded label indications can be a catalyst for the stock in 2022. While Biofrontera maintains a pos...
Previous 10 Next 10